Medical Disclaimer: This site provides informational comparisons only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your physician or pharmacist before making medication decisions.
Compare ADALIMUMAB-AFZB (ABRILADA) and ADALIMUMAB-AQVH (YUSIMRY) — clinical data, side effects, and patient experiences.
ABRILADA · TNF Inhibitor
How it works
12.1 Mechanism of Action Adalimumab products bind specifically to TNF-alpha and block its interaction with the p55 and p75 cell surface TNF receptors. Adalimumab products also lyse...
Approved for
YUSIMRY · TNF Inhibitor
How it works
12.1 Mechanism of Action Adalimumab products bind specifically to TNF-alpha and block its interaction with the p55 and p75 cell surface TNF receptors. Adalimumab products also lyse...
Approved for
Estimated frequency (%) based on clinical trial data
Based on 16 Reddit discussions
ADALIMUMAB-AFZB
70%
positive
10 threads
ADALIMUMAB-AQVH
17%
positive
6 threads
% of discussions mentioning each side effect
10 Reddit threads analysed for ADALIMUMAB-AFZB
Overall Sentiment
Slightly positive
Comparison Threads
0
Avg Post Score
195 upvotes
Most discussed side effects in community
TrumpRx is a recently launched prescription discount program that claims to lower drug prices through "Most-Favored-Nation" pricing and direct negotiations with manufacturers, allegedly forcing drugmakers to match the lowest prices available globally. I was curious whether these claims held up in pr
I am long on ATNF and there are some key details I’ve uncovered in my due diligence which might not be immediately apparent to a newcomer to this ticker. Company is targeting inflammation pain and fibrosis which are related in fascinating ways at a cellular level it takes a Phd to actually understan
After failing Remicade, Stelara, Abrilada, Entyvio and getting an Imuran & Methotrexate toxicity and resisting to steroids bc too many rounds and NO relief and severe disease, with Skyrizi, I FINALLY see a difference!!! And relief!!!!!!!!! And a light at the end of this darkness Crohn's depressi
Hi r/Hidradenitis, I’m Stage 2 with some tunnels, on weekly Abrilada injections and daily Clindamycin. After seeing Reddit posts hyping Desitin Maximum Strength Diaper Rash Cream (40% Zinc Oxide), I tried it for the first time on Sunday for abscesses in my groin, back, and a stubborn jaw abscess (my
Hi everyone. I made a reddit account specifically to connect with this community. I'm a 24F and have had uveitis since I was around 10. I was diagnosed with rheumatoid arthritis when I was 3 and got diagnosed with uveitis around 10. Since then, I have had a few eye surgeries and tried numerous amoun
I've been on Humira for the past 1.5 years and it seems to be working for me, i was taking it alongside Skyrizi after I had a temp ileostomy and have been taking it on its own for the past 6 months since I had a reversal. My GI just informed me they'll be switching me over to the biosimilar, Abrilad
I love participating in research studies that help our community! Even better when you get paid! Pillar Patient Advocates is seeking patients who are currently or previously have taken a Biosimilar medication to participate in a 45-minute web-based interview. Participants are paid $105 in appreciat
Hi everyone. I’m doing a project on Humira, and I’m getting flustered with the information that is online about the patent expiration and deferring of bio similar entry. From my understanding, the primary patent expiration date was 2016? But now I saw something about 2034? I also read about market e
Community discussions are sourced from public Reddit threads. Content reflects individual opinions and is not medical advice.
6 Reddit threads analysed for ADALIMUMAB-AQVH
Overall Sentiment
Mixed
Comparison Threads
0
Avg Post Score
22 upvotes
Most discussed side effects in community
$995 for a carton of 2 auto injectors vs Humira's $6922, good news for the patients. We can hope for more price reductions as the market is expecting at least 11 Humira biosimilars to be released.
This is my first time posting in this community, although I’ve lurked ever since I was diagnosed a little over a month ago. About 3 years ago I woke up with insane elbow pain out of nowhere. That was the only joint that hurt, but it was super intense considering when I went to bed the night before
My employer switched insurance companies at the beginning of the year. I am now on WPS and use SmithRx and Costco Speciality Pharmacy to get my meds delivered to my house each month. I am on Zeposia and have been since January 2023 without any relapses and no side effects. I got a letter from Smith
I have Crohn's disease and I'm trying to narrow down what health plan I wish to go with. I used to be on Humira, but my old insurance in the private sector moved me to a biosimilar named Yusimry. Based on my research, none of the Federal plans cover or supply this drug, so I'm willing to move to a b
Hey chat, has anyone switched to Yusimry from Humira? Or experiences with other biosimilars? I’m considering making the jump due to insurance reasons so plz lmk your experiences with Yusimry or other products.
Hi, I'm totally new to this subreddit, so please bear with me! I was diagnosed with Juvenile Idiopathic Arthritis (However, it's Rheumatoid in my jaw) in October of 2021. I've been on Humira for 4 year now since then and it has worked pretty well (besides irritation at my injection site, handled wit
Community discussions are sourced from public Reddit threads. Content reflects individual opinions and is not medical advice.
Both ADALIMUMAB-AFZB and ADALIMUMAB-AQVH belong to the TNF Inhibitor class. While they share a similar mechanism of action, differences in pharmacokinetics, dosing, and side effect profiles may make one more suitable than the other for individual patients. ADALIMUMAB-AFZB is administered via Oral, whereas ADALIMUMAB-AQVH uses Subcutaneous. Route of administration can affect onset of action and patient adherence.
Both medications are approved for inducing major clinical response, inhibiting the progression of structural damage, inhibiting the progression of structural damage, posterior. When two drugs treat the same condition, the choice between them often depends on the patient's medical history, other medications, tolerability, and prescriber preference.
ADALIMUMAB-AFZB carries 4 FDA warnings. ADALIMUMAB-AQVH carries 4 FDA warnings. Patients should discuss all warnings and contraindications with their healthcare provider before starting or switching medications..
This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.